Literature DB >> 25421667

Histone modifications associated with cancer cell migration and invasion.

Miki Hieda1, Nariaki Matsuura, Hiroshi Kimura.   

Abstract

Genome-wide aberrant histone modifications are present in a wide range of cancers, and they are associated with carcinogenesis and cancer progression. Aberrant histone modification patterns affect transcriptional regulation, chromosome stability, chromatin structure, chromatin remodeling, and DNA methylation; furthermore, these patterns can predict clinical outcome in many types of cancer. The main cause of poor clinical outcome is metastasis, which is strongly associated with tissue invasion at the primary tumor site. Invasion of cancer cells into surrounding tissue and the vasculature is an important initial step in tumor metastasis, and cell migration is a critical requirement for metastasis. Here, we describe the advantages of detecting global histone modifications by immunohistochemical analysis and provide a collection of protocols for assaying cell migration, invasion, and cell-extracellular matrix adhesion in vitro.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25421667     DOI: 10.1007/978-1-4939-1804-1_16

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  SUN1 splice variants, SUN1_888, SUN1_785, and predominant SUN1_916, variably function in directional cell migration.

Authors:  Yu Nishioka; Hiromasa Imaizumi; Junko Imada; Jun Katahira; Nariaki Matsuura; Miki Hieda
Journal:  Nucleus       Date:  2016-11       Impact factor: 4.197

2.  Inner Nuclear Membrane Protein, SUN1, is Required for Cytoskeletal Force Generation and Focal Adhesion Maturation.

Authors:  Nanami Ueda; Masashi Maekawa; Tsubasa S Matsui; Shinji Deguchi; Tomoyo Takata; Jun Katahira; Shigeki Higashiyama; Miki Hieda
Journal:  Front Cell Dev Biol       Date:  2022-05-18

3.  X-ray-enhanced cancer cell migration requires the linker of nucleoskeleton and cytoskeleton complex.

Authors:  Hiromasa Imaizumi; Katsutoshi Sato; Asuka Nishihara; Kazumasa Minami; Masahiko Koizumi; Nariaki Matsuura; Miki Hieda
Journal:  Cancer Sci       Date:  2018-04       Impact factor: 6.716

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.